Entering text into the input field will update the search result below

BioCryst Pharmaceuticals (NASDAQ:BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%)...

Feb. 04, 2010 7:18 AM ETBioCryst Pharmaceuticals, Inc. (BCRX) StockBCRXBy: Mohit Manghnani, SA News Editor
BioCryst Pharmaceuticals (NASDAQ:BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs. $23.6M. (PR)

Recommended For You

More Trending News

About BCRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BCRX--
BioCryst Pharmaceuticals, Inc.